{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:36:45Z","timestamp":1788899805283,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Commission of Zhejiang Province, Medical and health project","award":["2021KY727"],"award-info":[{"award-number":["2021KY727"]}]},{"name":"Hangzhou Municipal Health Commission, Medical and health science project","award":["A20210510"],"award-info":[{"award-number":["A20210510"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05658-y","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:36:05Z","timestamp":1768221365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Muscle Fibrosis in Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Diagnostic Advances, and Therapeutic Strategies"],"prefix":"10.1007","volume":"63","author":[{"given":"Yumeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"5658_CR1","doi-asserted-by":"publisher","unstructured":"JM S, A M, ST N, C L, FJ S, R R, M DC, S R, AC L, L D (2023) Skeletal muscle in amyotrophic lateral sclerosis. Brain : a J Neurol 146(11). https:\/\/doi.org\/10.1093\/brain\/awad202","DOI":"10.1093\/brain\/awad202"},{"key":"5658_CR2","doi-asserted-by":"publisher","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, Feldman EL (2022) Emerging insights into the complex genetics and pathophysiology of ALS. Lancet Neurol 21(5). https:\/\/doi.org\/10.1016\/S1474-4422(21)00414-2","DOI":"10.1016\/S1474-4422(21)00414-2"},{"key":"5658_CR3","doi-asserted-by":"publisher","unstructured":"R M, JM T, L M-M, M dlT, L M-G, T L-R, N M, P Z, AC C, R O (2021) What skeletal muscle has to say in amyotrophic lateral sclerosis: implications for therapy. British J Pharmacol 178(6). https:\/\/doi.org\/10.1111\/bph.15276","DOI":"10.1111\/bph.15276"},{"key":"5658_CR4","doi-asserted-by":"publisher","unstructured":"L D (2009) Oxidative stress sensitivity in ALS muscle cells. Exp Neurol 220(2). https:\/\/doi.org\/10.1016\/j.expneurol.2009.08.023","DOI":"10.1016\/j.expneurol.2009.08.023"},{"key":"5658_CR5","doi-asserted-by":"publisher","unstructured":"J H, CT P, T G (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28(2). https:\/\/doi.org\/10.1016\/j.nbd.2007.07.003","DOI":"10.1016\/j.nbd.2007.07.003"},{"key":"5658_CR6","doi-asserted-by":"publisher","unstructured":"M W, LJ M (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Human Mol Genet 19(11). https:\/\/doi.org\/10.1093\/hmg\/ddq106","DOI":"10.1093\/hmg\/ddq106"},{"key":"5658_CR7","doi-asserted-by":"publisher","unstructured":"N T, I C, GM C, S P (2022) Therapeutic targets in amyotrophic lateral sclerosis: focus on ion channels and skeletal muscle. Cells 11(3). https:\/\/doi.org\/10.3390\/cells11030415","DOI":"10.3390\/cells11030415"},{"key":"5658_CR8","doi-asserted-by":"publisher","unstructured":"MA C, K M, S S, D B, RL L (2017) Three distinct cell populations express extracellular matrix proteins and increase in number during skeletal muscle fibrosis. Am J Physiol Cell Physiol 312(2). https:\/\/doi.org\/10.1152\/ajpcell.00226.2016","DOI":"10.1152\/ajpcell.00226.2016"},{"key":"5658_CR9","doi-asserted-by":"publisher","unstructured":"RL L, SR W (2013) Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis. Am J Physiol Cell Physiol 305(3). https:\/\/doi.org\/10.1152\/ajpcell.00173.2013","DOI":"10.1152\/ajpcell.00173.2013"},{"key":"5658_CR10","doi-asserted-by":"publisher","unstructured":"JJ L-G, O I-J, L A-R, R J-S, D P-M, MI P-H, B R-B, J G-G, D DL-R (2024) Use of muscle ultrasonography in morphofunctional assessment of amyotrophic lateral sclerosis (ALS). Nutrients 16(7). https:\/\/doi.org\/10.3390\/nu16071021","DOI":"10.3390\/nu16071021"},{"key":"5658_CR11","doi-asserted-by":"publisher","unstructured":"A I, JS K, JS K, RS S, WT B, P K (2019) Role of transforming growth factor-\u03b2 in skeletal muscle fibrosis: a review. Int J Mol Sci 20(10). https:\/\/doi.org\/10.3390\/ijms20102446","DOI":"10.3390\/ijms20102446"},{"key":"5658_CR12","doi-asserted-by":"publisher","unstructured":"AL M, KR W (2011) Regeneration versus fibrosis in skeletal muscle. Curr Opin Rheumatol 23(6). https:\/\/doi.org\/10.1097\/BOR.0b013e32834bac92","DOI":"10.1097\/BOR.0b013e32834bac92"},{"key":"5658_CR13","doi-asserted-by":"publisher","unstructured":"K S, J O, A K, K B, K K, Y L (2022) The pathophysiology and treatment of musculoskeletal fibrosis. J Cell Biochem 123(5). https:\/\/doi.org\/10.1002\/jcb.30217","DOI":"10.1002\/jcb.30217"},{"key":"5658_CR14","doi-asserted-by":"publisher","unstructured":"D G, O C, DL R, JP E, B vZ, E B (2017) ALS skeletal muscle shows enhanced TGF-\u03b2 signaling, fibrosis and induction of fibro\/adipogenic progenitor markers. PloS One 12(5). https:\/\/doi.org\/10.1371\/journal.pone.0177649","DOI":"10.1371\/journal.pone.0177649"},{"key":"5658_CR15","doi-asserted-by":"publisher","unstructured":"M M, V C, R C, P R, ME C, E M, M P, B T, V F, G S, M P, A P, M G (2019) Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients. Neurobiol Aging 82. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.07.001","DOI":"10.1016\/j.neurobiolaging.2019.07.001"},{"key":"5658_CR16","doi-asserted-by":"publisher","unstructured":"DY L, YN K, K L, SJ K, JJ S (2024) Dual effects of TGF-\u03b2 inhibitor in ALS - inhibit contracture and neurodegeneration. J Neurochem 168(9). https:\/\/doi.org\/10.1111\/jnc.16102","DOI":"10.1111\/jnc.16102"},{"key":"5658_CR17","doi-asserted-by":"publisher","unstructured":"MG M, D C, C C, CP V, Y V, E B, C C-V (2013) Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF\/CCN-2). Cell Tissue Res 353(1). https:\/\/doi.org\/10.1007\/s00441-013-1642-6","DOI":"10.1007\/s00441-013-1642-6"},{"key":"5658_CR18","doi-asserted-by":"publisher","unstructured":"WG S, E A, M R, J A, D T (2003) Increased expression of connective tissue growth factor in amyotrophic lateral sclerosis human spinal cord. Acta Neuropathologica 106(5). https:\/\/doi.org\/10.1007\/s00401-003-0741-y","DOI":"10.1007\/s00401-003-0741-y"},{"key":"5658_CR19","doi-asserted-by":"publisher","unstructured":"D G, DL R, LM C, FA C, W C, KE L, B vZ, E B (2018) The inhibition of CTGF\/CCN2 activity improves muscle and locomotor function in a murine ALS model. Human Mol Genet 27(16). https:\/\/doi.org\/10.1093\/hmg\/ddy204","DOI":"10.1093\/hmg\/ddy204"},{"key":"5658_CR20","doi-asserted-by":"publisher","unstructured":"AG L, RJ D, PR P, BA H, SN P, MF B (2023) Blocking CCN2 reduces established palmar neuromuscular fibrosis and improves function following repetitive overuse injury. Int J Mol Sci 24(18). https:\/\/doi.org\/10.3390\/ijms241813866","DOI":"10.3390\/ijms241813866"},{"key":"5658_CR21","doi-asserted-by":"publisher","unstructured":"AS B, MJ C, S R, M L, CJ K, C K, TA R (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (New York, NY) 317(5839). https:\/\/doi.org\/10.1126\/science.1144090","DOI":"10.1126\/science.1144090"},{"key":"5658_CR22","doi-asserted-by":"publisher","unstructured":"T L, LR S (2023) Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis. Am J Physiol Cell Physiol 325(4). https:\/\/doi.org\/10.1152\/ajpcell.00245.2023","DOI":"10.1152\/ajpcell.00245.2023"},{"key":"5658_CR23","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080509","author":"W Wang","year":"2009","unstructured":"Wang W, Pan H, Murray K, Jefferson BS, Li Y (2009) Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am J Pathol. https:\/\/doi.org\/10.2353\/ajpath.2009.080509","journal-title":"Am J Pathol"},{"key":"5658_CR24","doi-asserted-by":"publisher","unstructured":"X C, Y L (2009) Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis. Cell Adhes Migr 3(4). https:\/\/doi.org\/10.4161\/cam.3.4.9338","DOI":"10.4161\/cam.3.4.9338"},{"key":"5658_CR25","doi-asserted-by":"publisher","unstructured":"P M-C, AL S (2015) Macrophages decide between regeneration and fibrosis in muscle. Trends Endocrinol Metabol: TEM 26(9). https:\/\/doi.org\/10.1016\/j.tem.2015.07.005","DOI":"10.1016\/j.tem.2015.07.005"},{"key":"5658_CR26","doi-asserted-by":"publisher","unstructured":"C R-G, O C, E B (2018) Expression of CTGF\/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin\/FAK axis. Am J Physiol Cell Physiol 314(4). https:\/\/doi.org\/10.1152\/ajpcell.00013.2017","DOI":"10.1152\/ajpcell.00013.2017"},{"key":"5658_CR27","doi-asserted-by":"publisher","unstructured":"C V, LM Z, C C-V, P C, R F, E B (2008) Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF\/CCN2), which induces their dedifferentiation. J Cell Physiol 215(2). https:\/\/doi.org\/10.1002\/jcp.21324","DOI":"10.1002\/jcp.21324"},{"key":"5658_CR28","doi-asserted-by":"publisher","unstructured":"R V-T, DL R, KE L, E B (2020) Role of hypoxia in skeletal muscle fibrosis: synergism between hypoxia and TGF-\u03b2 signaling upregulates CCN2\/CTGF expression specifically in muscle fibers. Matrix Biol: J Int Soc Matrix Biol 87. https:\/\/doi.org\/10.1016\/j.matbio.2019.09.003","DOI":"10.1016\/j.matbio.2019.09.003"},{"key":"5658_CR29","doi-asserted-by":"publisher","unstructured":"X Z, L H, L W, Y W, E Y, B W, Q Z, P Z, X Z, J Y (2024) CLIC5 promotes myoblast differentiation and skeletal muscle regeneration via the BGN-mediated canonical Wnt\/\u03b2-catenin signaling pathway. Sci Adv 10(41). https:\/\/doi.org\/10.1126\/sciadv.adq6795","DOI":"10.1126\/sciadv.adq6795"},{"key":"5658_CR30","doi-asserted-by":"publisher","unstructured":"L M, M P, D S, U E, F L, D P, MV A, C N, S G, M DB, R R-G, L G, S M, V P, C S, A S, PL P (2018) Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. Nat Cell biol 20(8). https:\/\/doi.org\/10.1038\/s41556-018-0151-y","DOI":"10.1038\/s41556-018-0151-y"},{"key":"5658_CR31","doi-asserted-by":"publisher","unstructured":"M C-S, J F-C, A C-C, FS G, A B-P, J C, JC C, E B (2023) Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway. Matrix Biol: J Int Soc Matrix Biol 119. https:\/\/doi.org\/10.1016\/j.matbio.2023.03.010","DOI":"10.1016\/j.matbio.2023.03.010"},{"key":"5658_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2014","author":"A Uezumi","year":"2010","unstructured":"Uezumi A, Fukada S-i, Yamamoto N, Takeda Si, Tsuchida K, Uezumi A, Fukada S-i, Yamamoto N, et al. (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb2014","journal-title":"Nat Cell Biol"},{"key":"5658_CR33","doi-asserted-by":"publisher","unstructured":"W C, W Y, TG V, T S (2022) Bidirectional roles of skeletal muscle fibro-adipogenic progenitors in homeostasis and disease. Ageing Res Rev 80. https:\/\/doi.org\/10.1016\/j.arr.2022.101682","DOI":"10.1016\/j.arr.2022.101682"},{"key":"5658_CR34","doi-asserted-by":"publisher","unstructured":"S A, N DA (2022) Fibrosis as a common trait in amyotrophic lateral sclerosis tissues. Neural Regen Res 17(1). https:\/\/doi.org\/10.4103\/1673-5374.314302","DOI":"10.4103\/1673-5374.314302"},{"key":"5658_CR35","doi-asserted-by":"publisher","unstructured":"O C, DL R, JE O, HC O, E B (2016) Connective tissue cells expressing fibro\/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis. Cell Tissue Res 364(3). https:\/\/doi.org\/10.1007\/s00441-015-2343-0","DOI":"10.1007\/s00441-015-2343-0"},{"key":"5658_CR36","doi-asserted-by":"publisher","unstructured":"J I, Z S, B D (2002) Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine 20(5). https:\/\/doi.org\/10.1006\/cyto.2002.2005","DOI":"10.1006\/cyto.2002.2005"},{"key":"5658_CR37","doi-asserted-by":"publisher","unstructured":"G C, D J, C G-J, JM K, PK F, Q N, N P, K M, L T, S M, BS H, J D, A S, E M, I M, M D, S O, T J, CP H, V K, AL M, Q N, LM W, SQ H, T M, MW H, S B, JK J, DR G, Q S, K K, M S, MJ S, JR Z, SA V (2023) Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. Sci Adv 9(27). https:\/\/doi.org\/10.1126\/sciadv.add9984","DOI":"10.1126\/sciadv.add9984"},{"key":"5658_CR38","doi-asserted-by":"publisher","unstructured":"C C-V, MG M, D C, CP V, E B (2012) Angiotensin II receptor type 1 blockade decreases CTGF\/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. J Cell Mol Med 16(4). https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01354.x","DOI":"10.1111\/j.1582-4934.2011.01354.x"},{"key":"5658_CR39","doi-asserted-by":"publisher","unstructured":"DAG M, D C, ER C (2024) SERCA1 overexpression in skeletal muscle attenuates muscle atrophy and improves motor function in a mouse model of ALS. J Neuromuscul Dis 11(2). https:\/\/doi.org\/10.3233\/JND-230123","DOI":"10.3233\/JND-230123"},{"key":"5658_CR40","doi-asserted-by":"publisher","unstructured":"C Q, A B, F R, C V, A F, ST N, JP L (2021) Skeletal muscle metabolism: origin or prognostic factor for amyotrophic lateral sclerosis (ALS) development?. Cells 10(6). https:\/\/doi.org\/10.3390\/cells10061449","DOI":"10.3390\/cells10061449"},{"key":"5658_CR41","doi-asserted-by":"publisher","unstructured":"E D, C V (2023) Muscle involvement in amyotrophic lateral sclerosis: understanding the pathogenesis and advancing therapeutics. Biomolecules 13(11). https:\/\/doi.org\/10.3390\/biom13111582","DOI":"10.3390\/biom13111582"},{"key":"5658_CR42","doi-asserted-by":"publisher","unstructured":"QJ Z, J L, YL W, L C, Y D, FZ Z, HH S, AW L, YY L, QF G, MT L, W H, LQ X, WL Z, L F, MC C, ZF F, WJ C, J Z, ZQ W, N W, Y F (2024) Detection of pTDP-43 via routine muscle biopsy: a promising diagnostic biomarker for amyotrophic lateral sclerosis. Brain Pathol (Zurich, Switzerland) 34(6). https:\/\/doi.org\/10.1111\/bpa.13261","DOI":"10.1111\/bpa.13261"},{"key":"5658_CR43","doi-asserted-by":"publisher","unstructured":"AB M-B, D B, ECA A, L S, P LdS, Y F, PG C (2021) Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography. Sci Rep 11(1). https:\/\/doi.org\/10.1038\/s41598-020-78747-8","DOI":"10.1038\/s41598-020-78747-8"},{"key":"5658_CR44","doi-asserted-by":"publisher","unstructured":"J R-D, ME DB-A, JI T-F, MJ C, JF V-C, JJ M-P (2019) Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis. Eur Radiol 29(8). https:\/\/doi.org\/10.1007\/s00330-018-5943-8","DOI":"10.1007\/s00330-018-5943-8"},{"key":"5658_CR45","doi-asserted-by":"publisher","unstructured":"R EK, E M, H C-G, C G, A F, F L, V F, B A, A L, N S, P C, M F-B (2024) Assessment of whole-body muscle MRI for the early diagnosis of amyotrophic lateral sclerosis. Eur J Radiol 176. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111481","DOI":"10.1016\/j.ejrad.2024.111481"},{"key":"5658_CR46","doi-asserted-by":"publisher","unstructured":"N W, HP M, P M, V R, AC L, J K (2024) The central pattern of weakness of ALS: morphological correlates in whole-body muscle MRI. Ann Clin Transl Neurol 11(4). https:\/\/doi.org\/10.1002\/acn3.52019","DOI":"10.1002\/acn3.52019"},{"key":"5658_CR47","doi-asserted-by":"publisher","unstructured":"T L, A S, K W, N GH, D M, M S, GR F, HC L, TD H (2021) MRI DTI and PDFF as biomarkers for lower motor neuron degeneration in ALS. Front Neurosci 15. https:\/\/doi.org\/10.3389\/fnins.2021.682126","DOI":"10.3389\/fnins.2021.682126"},{"key":"5658_CR48","doi-asserted-by":"publisher","unstructured":"C N, NL B, A H (2024) Disruption of neuromuscular junction following spinal cord injury and motor neuron diseases. Int J Molecul Sci 25(6). https:\/\/doi.org\/10.3390\/ijms25063520","DOI":"10.3390\/ijms25063520"},{"key":"5658_CR49","doi-asserted-by":"publisher","unstructured":"PK P, LE E, IM A, G M, G G, D W, C L (2023) Multimodal MRI improves diagnostic accuracy and sensitivity to longitudinal change in amyotrophic lateral sclerosis. Commun Med 3(1). https:\/\/doi.org\/10.1038\/s43856-023-00318-5","DOI":"10.1038\/s43856-023-00318-5"},{"key":"5658_CR50","doi-asserted-by":"publisher","unstructured":"IMP A, S O, S P, H JS, MJ Z (2011) Muscle changes in amyotrophic lateral sclerosis: a longitudinal ultrasonography study. Clin Neurophysiol: off J Int Fed Clin Neurophysiol 122(3). https:\/\/doi.org\/10.1016\/j.clinph.2010.07.023","DOI":"10.1016\/j.clinph.2010.07.023"},{"key":"5658_CR51","doi-asserted-by":"publisher","unstructured":"L F, C M, BM S, A M (2019) Signals from the niche: insights into the role of IGF-1 and IL-6 in modulating skeletal muscle fibrosis. Cells 8(3). https:\/\/doi.org\/10.3390\/cells8030232","DOI":"10.3390\/cells8030232"},{"key":"5658_CR52","doi-asserted-by":"publisher","unstructured":"TA J, TL J, M K, H K, M J (2005) Muscle injuries: biology and treatment. Am J Sports Med 33(5). https:\/\/doi.org\/10.1177\/0363546505274714","DOI":"10.1177\/0363546505274714"},{"key":"5658_CR53","doi-asserted-by":"publisher","unstructured":"TJ W, DW G, DGD N, EL W, AC S (2019) Quality over quantity? Association of skeletal muscle myosteatosis and myofibrosis on physical function in chronic kidney disease. Nephrol, Dial, Transpl: off Publ Eur Dial Transpl Assoc- Eur Renal Assoc 34(8). https:\/\/doi.org\/10.1093\/ndt\/gfy139","DOI":"10.1093\/ndt\/gfy139"},{"key":"5658_CR54","doi-asserted-by":"publisher","unstructured":"O K-C, T G, B I, I Y (2021) Intrarater and interrater reliability of Heckmatt scoring system in amyotrophic lateral sclerosis. J Clin Neurophysio: off Publ Am Electroencephalographic Soc 38(4). https:\/\/doi.org\/10.1097\/WNP.0000000000000690","DOI":"10.1097\/WNP.0000000000000690"},{"key":"5658_CR55","doi-asserted-by":"publisher","unstructured":"J G, E S, R H, A S, Y Y (2024) Therapeutics targeting skeletal muscle in amyotrophic lateral sclerosis. Biomolecules 14(7). https:\/\/doi.org\/10.3390\/biom14070878","DOI":"10.3390\/biom14070878"},{"key":"5658_CR56","doi-asserted-by":"publisher","unstructured":"S S, I S, A F, C V (2021) Skeletal muscle in ALS: an unappreciated therapeutic opportunity?. Cells 10(3). https:\/\/doi.org\/10.3390\/cells10030525","DOI":"10.3390\/cells10030525"},{"key":"5658_CR57","doi-asserted-by":"publisher","unstructured":"Y Z, Y Z, M L, J B, H W, X P, R D, J W, X H (2024) Prognostic value of systemic inflammation, nutritional status and sarcopenia in patients with amyotrophic lateral sclerosis. J Cachexia, Sarcopenia Muscle 15(6). https:\/\/doi.org\/10.1002\/jcsm.13618","DOI":"10.1002\/jcsm.13618"},{"key":"5658_CR58","doi-asserted-by":"publisher","unstructured":"R D (2012) Electromyography and muscle ultrasound in ALS diagnosis, complementary or competitive?. Clin Neurophysiol: off J Int Fed Clin Neurophysiol 123(8). https:\/\/doi.org\/10.1016\/j.clinph.2011.12.007","DOI":"10.1016\/j.clinph.2011.12.007"},{"key":"5658_CR59","doi-asserted-by":"publisher","unstructured":"T N, T A, E B, FE B, H A, M H (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 583(2). https:\/\/doi.org\/10.1016\/j.febslet.2008.12.031","DOI":"10.1016\/j.febslet.2008.12.031"},{"key":"5658_CR60","doi-asserted-by":"publisher","unstructured":"F M, M T, T K, Y M, K T, H K, M T, T I, O O, A K, K W (2019) Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathologica Commun 7(1). https:\/\/doi.org\/10.1186\/s40478-019-0824-1","DOI":"10.1186\/s40478-019-0824-1"},{"key":"5658_CR61","doi-asserted-by":"publisher","unstructured":"T K, H M, T M, Y I, T S, K K, H K, T T, H M (2022) TDP-43 accumulation within intramuscular nerve bundles of patients with amyotrophic lateral sclerosis. JAMA Neurol 79(7). https:\/\/doi.org\/10.1001\/jamaneurol.2022.1113","DOI":"10.1001\/jamaneurol.2022.1113"},{"key":"5658_CR62","doi-asserted-by":"publisher","unstructured":"EM L, S P, J D, C I, S C, DD D, ME J, YM A, P K, CV L, A P, TE L, CC W (2024) Seeding-competent TDP-43 persists in human patient and mouse muscle. Sci Transl Med 16(775). https:\/\/doi.org\/10.1126\/scitranslmed.adp5730","DOI":"10.1126\/scitranslmed.adp5730"},{"key":"5658_CR63","doi-asserted-by":"publisher","unstructured":"VI K, K O, DY K, X L, A P, JS H, M L, G B, DW C, JM R (2024) CK1\u03b4\/\u03b5-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis. Acta Neuropathologica Commun 12(1). https:\/\/doi.org\/10.1186\/s40478-024-01902-z","DOI":"10.1186\/s40478-024-01902-z"},{"key":"5658_CR64","doi-asserted-by":"publisher","unstructured":"MB D, MI A, S A, K C, TL P, EH D, CL C, A B, KD B, AM B, KJ B, DA D, JM F, EJ M, JM M, JL P, ZA R, MJ T, JA D, NJ C, MA G (2025) A cellular model of TDP-43 induces phosphorylated TDP-43 aggregation with distinct changes in solubility and autophagy dysregulation. FEBS J. https:\/\/doi.org\/10.1111\/febs.17413","DOI":"10.1111\/febs.17413"},{"key":"5658_CR65","doi-asserted-by":"publisher","unstructured":"R C, T Y, B J, W X, Y Y, N W, HI L, S W, X Z, W Y, H C, Z L, G L, TS B, J L, J X (2023) CircTmeff1 promotes muscle atrophy by interacting with TDP-43 and encoding a novel TMEFF1\u2013339aa protein. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 10(17). https:\/\/doi.org\/10.1002\/advs.202206732","DOI":"10.1002\/advs.202206732"},{"key":"5658_CR66","doi-asserted-by":"publisher","unstructured":"PC C, D W, CJ H, HY C, YC H, CC H (2020) Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: a longitudinal follow-up study. J Neurol Sci 418. https:\/\/doi.org\/10.1016\/j.jns.2020.117070","DOI":"10.1016\/j.jns.2020.117070"},{"key":"5658_CR67","doi-asserted-by":"publisher","unstructured":"M C, S \u00d6, C F, W M, L K, E M, J B, C D, O P, NC C, X W, LS S, J P, E S, AA K, P K, T K, IR V, O K, A S, DC H, K F, C M, C M, P W, B F, M B, R G, E D, J W, N H, M B, I Z, A F, PJ N, E D, W G, E I, K B, D J, R P, BS R, F H, O W, J L, S T, I K, D G, J P, T G, K B, D M, M Z, M S, C W, J S-G, J T-S, MA S-S, D A, S R-G, J F, \u00c1 C, A L, R R-G, I I-G, M W, I F, S R, L B, MT H, F B, A R, M S, R B, A H, J H, M N, NR B, RJ B, P R, P H, O D-I, G H, A H, A S (2024) Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med 30(6). https:\/\/doi.org\/10.1038\/s41591-024-02937-4","DOI":"10.1038\/s41591-024-02937-4"},{"key":"5658_CR68","doi-asserted-by":"publisher","unstructured":"L C, SS H (2013) Vitamin D and its role in skeletal muscle. Calcified Tissue Int 92(2). https:\/\/doi.org\/10.1007\/s00223-012-9645-y","DOI":"10.1007\/s00223-012-9645-y"},{"key":"5658_CR69","doi-asserted-by":"publisher","unstructured":"CM L, CR B, AR K, BD M, NT T, AM Z, CS F, JL F (2021) Vitamin D promotes skeletal muscle regeneration and mitochondrial health. Front Physiol 12. https:\/\/doi.org\/10.3389\/fphys.2021.660498","DOI":"10.3389\/fphys.2021.660498"},{"key":"5658_CR70","doi-asserted-by":"publisher","unstructured":"R S, X Z, OK P-S, KA E (2012) VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303(4). https:\/\/doi.org\/10.1152\/ajpcell.00014.2012","DOI":"10.1152\/ajpcell.00014.2012"},{"key":"5658_CR71","doi-asserted-by":"publisher","unstructured":"Y S, M K, Y K, I L, T A, S Z, M B, D W, T K, PH K (2020) The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis. J Steroid Biochem Mol Biol 200. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105650","DOI":"10.1016\/j.jsbmb.2020.105650"},{"key":"5658_CR72","doi-asserted-by":"publisher","unstructured":"DL R, D G, J F-C, O C, CP V, JE M-U, KE L, E B (2019) Denervation-induced skeletal muscle fibrosis is mediated by CTGF\/CCN2 independently of TGF-\u03b2. Matrix Biol J Int Soc Matrix Biol 82. https:\/\/doi.org\/10.1016\/j.matbio.2019.01.002","DOI":"10.1016\/j.matbio.2019.01.002"},{"key":"5658_CR73","doi-asserted-by":"publisher","unstructured":"AP T, A P, CY M, H SN, MJ M (2011) Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-\u03b21 blocker. Muscle Nerve 43(1). https:\/\/doi.org\/10.1002\/mus.21869","DOI":"10.1002\/mus.21869"},{"key":"5658_CR74","doi-asserted-by":"publisher","unstructured":"S A, TK C, S G, SR S, Y W, L L, C V, NT G, M R, R T (2014) Sharp-1 regulates TGF-\u03b2 signaling and skeletal muscle regeneration. J Cell Sci 127(Pt 3). https:\/\/doi.org\/10.1242\/jcs.136648","DOI":"10.1242\/jcs.136648"},{"key":"5658_CR75","doi-asserted-by":"publisher","unstructured":"S H, JS S, AJ S, I G, KE D, ST E, AL C, D D, SC G, KA B, CA S, MM L (2015) Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des, Dev Ther 9. https:\/\/doi.org\/10.2147\/DDDT.S86621","DOI":"10.2147\/DDDT.S86621"},{"key":"5658_CR76","doi-asserted-by":"publisher","unstructured":"X J, H W, Z W, X Z, M Z, Y Z, R T, Y L, J L, L W (2018) Specific Inhibitor of Smad3 (SIS3) Attenuates fibrosis, apoptosis, and inflammation in unilateral ureteral obstruction kidneys by inhibition of transforming growth factor \u03b2 (TGF-\u03b2)\/Smad3 signaling. Med Sci Monit Int Med J Exp Clin Res 24. https:\/\/doi.org\/10.12659\/msm.909236","DOI":"10.12659\/msm.909236"},{"key":"5658_CR77","doi-asserted-by":"publisher","unstructured":"TC L, DA P, M F, HT N, CA M, A B, D S (2009) Small interfering RNAs (siRNAs) targeting TGF-beta1 mRNA suppress asbestos-induced expression of TGF-beta1 and CTGF in fibroblasts. J Environ Pathol, Toxicol Oncol Off Organ Int Soc Environ Toxicol Cancer 28(2). https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.v28.i2.30","DOI":"10.1615\/jenvironpatholtoxicoloncol.v28.i2.30"},{"key":"5658_CR78","doi-asserted-by":"publisher","unstructured":"K C, N Y, RI M (2009) TGF-beta1 gene silencing for treating liver fibrosis. Mol Pharm 6(3). https:\/\/doi.org\/10.1021\/mp9000469","DOI":"10.1021\/mp9000469"},{"key":"5658_CR79","doi-asserted-by":"publisher","unstructured":"C R, MJA W (2018) Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol 14(1). https:\/\/doi.org\/10.1038\/nrneurol.2017.148","DOI":"10.1038\/nrneurol.2017.148"},{"key":"5658_CR80","doi-asserted-by":"publisher","unstructured":"Y S, Y L, H W, H L, S L, J C, H Y (2017) miR-146a-5p acts as a negative regulator of TGF-\u03b2 signaling in skeletal muscle after acute contusion. Acta Biochimica et Biophysica Sinica 49(7). https:\/\/doi.org\/10.1093\/abbs\/gmx052","DOI":"10.1093\/abbs\/gmx052"},{"key":"5658_CR81","doi-asserted-by":"publisher","unstructured":"MG M, J G, C C-V, D C, KE L, R G, E B (2013) Reducing CTGF\/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Human Mol Genet 22(24). https:\/\/doi.org\/10.1093\/hmg\/ddt352","DOI":"10.1093\/hmg\/ddt352"},{"key":"5658_CR82","doi-asserted-by":"publisher","unstructured":"MF B, BA H, M A, MY H, LJ H, GE C, SN P (2020) Blocking CTGF\/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury. FASEB J Off Publ Fed Am Soc Exp Biol 34(5). https:\/\/doi.org\/10.1096\/fj.202000240RR","DOI":"10.1096\/fj.202000240RR"},{"key":"5658_CR83","doi-asserted-by":"publisher","unstructured":"L R, ER FP, U C, C A, DJ L, KR F, N E, R P, MB S, J G, KH PY, T N, S P, M Z, E G, E K, G R (2020) Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Respir Med 8(1). https:\/\/doi.org\/10.1016\/S2213-2600(19)30262-0","DOI":"10.1016\/S2213-2600(19)30262-0"},{"key":"5658_CR84","doi-asserted-by":"publisher","unstructured":"Picozzi VJ, Pishvaian MJ, Mody K, Winter JM, Glaspy JA, Larson T, Matrana MR, Saikali K, Carney M, Porter S, Yu P, Kouchakji E, Carrier E (2018) Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine\/nab-paclitaxel in phase 1\/2 clinical study for the treatment of locally advanced pancreatic cancer patients. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.4016","DOI":"10.1200\/JCO.2018.36.15_suppl.4016"},{"key":"5658_CR85","doi-asserted-by":"publisher","unstructured":"D vdB, B L, F D, P M, A G (2014) [Antifibrotic treatment]. Deutsche medizinische Wochenschrift (1946) 139(49). https:\/\/doi.org\/10.1055\/s-0034-1387450","DOI":"10.1055\/s-0034-1387450"},{"key":"5658_CR86","doi-asserted-by":"publisher","unstructured":"S O, S A, T T, T I, T R, M N (2022) Quercetin attenuates adipogenesis and fibrosis in human skeletal muscle. Biochem Biophys Res Commun 615. https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.033","DOI":"10.1016\/j.bbrc.2022.05.033"},{"key":"5658_CR87","doi-asserted-by":"publisher","unstructured":"JM S, JH P, IH P, HM L (2015) Pirfenidone inhibits transforming growth factor \u03b21-induced extracellular matrix production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy 29(6). https:\/\/doi.org\/10.2500\/ajra.2015.29.4221","DOI":"10.2500\/ajra.2015.29.4221"},{"key":"5658_CR88","doi-asserted-by":"publisher","unstructured":"X W, X X, Y S, Y Z, G L, F W, Q D, H Y (2025) Use quercetin for pulmonary fibrosis: a preclinical systematic review and meta-analysis. Inflammopharmacology 33(4). https:\/\/doi.org\/10.1007\/s10787-025-01678-1","DOI":"10.1007\/s10787-025-01678-1"},{"key":"5658_CR89","doi-asserted-by":"publisher","unstructured":"YW S, YY Z, XJ K, XJ W, ZF C, P C (2018) Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-\u03b21\/Smad\/CTGF signaling pathway. Eur J Pharmacol 822. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.027","DOI":"10.1016\/j.ejphar.2018.01.027"},{"key":"5658_CR90","doi-asserted-by":"publisher","unstructured":"Z L, X L, B W, Y N, J W, Q W, C G (2017) Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Nephrology (Carlton, Vic) 22(8). https:\/\/doi.org\/10.1111\/nep.12831","DOI":"10.1111\/nep.12831"},{"key":"5658_CR91","doi-asserted-by":"publisher","unstructured":"H K, CH B, RB L, JW C, WS Y, SK L (2017) Anti-fibrotic effect of losartan, an angiotensin II receptor blocker, is mediated through inhibition of ER stress via up-regulation of SIRT1, followed by induction of HO-1 and thioredoxin. Int J Mol Sci 18(2). https:\/\/doi.org\/10.3390\/ijms18020305","DOI":"10.3390\/ijms18020305"},{"key":"5658_CR92","doi-asserted-by":"publisher","unstructured":"TN B, E A-M, R M, R M, C VE, JL S, JD W, CW W, RD C (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 3(82). https:\/\/doi.org\/10.1126\/scitranslmed.3002227","DOI":"10.1126\/scitranslmed.3002227"},{"key":"5658_CR93","doi-asserted-by":"publisher","unstructured":"H L, S Y, G L, J L, K Z, Z Z, S Z, L Y, Y L (2024) Satellite cell-derived exosomes: a novel approach to alleviate skeletal muscle atrophy and fibrosis. Adv Biol 8(4). https:\/\/doi.org\/10.1002\/adbi.202300558","DOI":"10.1002\/adbi.202300558"},{"key":"5658_CR94","doi-asserted-by":"publisher","unstructured":"AL S, P M-C (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316(18). https:\/\/doi.org\/10.1016\/j.yexcr.2010.05.035","DOI":"10.1016\/j.yexcr.2010.05.035"},{"key":"5658_CR95","doi-asserted-by":"publisher","unstructured":"V S, S C, L G, C M, I B, M S, T R, A R-M, L M, P F, G B, M DB, G F, A T, X S, J R, BG B, M M, S M, PL P (2014) HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 28(8). https:\/\/doi.org\/10.1101\/gad.234468.113","DOI":"10.1101\/gad.234468.113"},{"key":"5658_CR96","doi-asserted-by":"publisher","unstructured":"A M, G D, C C, E O, M C, V F, A P, B C, E L, G R, P C, C R, C G, MC G, E P, M I (2019) Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study. Sci Rep 9(1). https:\/\/doi.org\/10.1038\/s41598-019-39313-z","DOI":"10.1038\/s41598-019-39313-z"},{"key":"5658_CR97","doi-asserted-by":"publisher","unstructured":"J G, D G, R E-R, C T, E B (2021) Reduced RECK levels accelerate skeletal muscle differentiation, improve muscle regeneration, and decrease fibrosis. FASEB J Off Publ Fed Am Soc Exp Biol 35(5). https:\/\/doi.org\/10.1096\/fj.202001646RR","DOI":"10.1096\/fj.202001646RR"},{"key":"5658_CR98","doi-asserted-by":"publisher","unstructured":"E T, JA D (2016) Skeletal muscle loading changes its regenerative capacity. Sports Med (Auckland, NZ) 46(6). https:\/\/doi.org\/10.1007\/s40279-015-0462-0","DOI":"10.1007\/s40279-015-0462-0"},{"key":"5658_CR99","doi-asserted-by":"publisher","unstructured":"T S, JP N, BR M, S J, LB V, LJ vL, G P (2015) Satellite cells in human skeletal muscle plasticity. Front Physiol 6. https:\/\/doi.org\/10.3389\/fphys.2015.00283","DOI":"10.3389\/fphys.2015.00283"},{"key":"5658_CR100","doi-asserted-by":"publisher","unstructured":"JK P, JS K, DL M, JM C, MM B (2008) Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol (Bethesda, Md : 1985) 104(6). https:\/\/doi.org\/10.1152\/japplphysiol.01215.2007","DOI":"10.1152\/japplphysiol.01215.2007"},{"key":"5658_CR101","doi-asserted-by":"publisher","unstructured":"CS F, B N, J M, MF U, PM W, PA K, CA P (2014) Fibre type-specific satellite cell response to aerobic training in sedentary adults. J Physiol 592(12). https:\/\/doi.org\/10.1113\/jphysiol.2014.271288","DOI":"10.1113\/jphysiol.2014.271288"},{"key":"5658_CR102","doi-asserted-by":"publisher","unstructured":"CM A, M T, O T, A T (2014) Acute hamstring injuries in Swedish elite sprinters and jumpers: a prospective randomised controlled clinical trial comparing two rehabilitation protocols. British J Sports Med 48(7). https:\/\/doi.org\/10.1136\/bjsports-2013-093214","DOI":"10.1136\/bjsports-2013-093214"},{"key":"5658_CR103","doi-asserted-by":"publisher","unstructured":"H R-B, B S, B C, S B, A P, X B, N K (2008) Recovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activity. Am J Physiol Cell Physiol 294(2). https:\/\/doi.org\/10.1152\/ajpcell.00355.2007","DOI":"10.1152\/ajpcell.00355.2007"},{"key":"5658_CR104","doi-asserted-by":"publisher","unstructured":"D P, SG K, JS P, YJ C, MC C (2020) Can therapeutic exercise slow down progressive functional decline in patients with amyotrophic lateral sclerosis? A meta-analysis. Front Neurol 11. https:\/\/doi.org\/10.3389\/fneur.2020.00853","DOI":"10.3389\/fneur.2020.00853"},{"key":"5658_CR105","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2009.169748","author":"S Deforges","year":"2009","unstructured":"Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, L\u00e9colle S, Lopes P, Vidal P-P, et al. (2009) Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. https:\/\/doi.org\/10.1113\/jphysiol.2009.169748","journal-title":"J Physiol"},{"key":"5658_CR106","doi-asserted-by":"publisher","unstructured":"SM M, S S, ABH H, I M, L P, LA M, H S-S, O C, KE W, G F, JS M, GE T, VN K, M K, M R, W W, MR D, R P, PS Z, DJ W, T E, FS T (2018) Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering. Cell Rep 23(3). https:\/\/doi.org\/10.1016\/j.celrep.2018.03.091","DOI":"10.1016\/j.celrep.2018.03.091"},{"key":"5658_CR107","doi-asserted-by":"publisher","unstructured":"A N, A S, UM K (2019) Toward building the neuromuscular junction: in vitro models to study synaptogenesis and neurodegeneration. ACS Omega 4(7). https:\/\/doi.org\/10.1021\/acsomega.9b00973","DOI":"10.1021\/acsomega.9b00973"},{"key":"5658_CR108","doi-asserted-by":"publisher","unstructured":"S B, M G, M M, S K, C A, C C, S Z, M M (2018) Tackling muscle fibrosis: from molecular mechanisms to next generation engineered models to predict drug delivery. Adv Drug Deliv Rev 129. https:\/\/doi.org\/10.1016\/j.addr.2018.02.009","DOI":"10.1016\/j.addr.2018.02.009"},{"key":"5658_CR109","doi-asserted-by":"publisher","unstructured":"S A-M, S K-H, M R-T, B L, R A, F R, A R-M, H A, B A (2024) Neuromuscular junction-on-a-chip for amyotrophic lateral sclerosis modeling. Methods Molecul Biol (Clifton, NJ) 2736. https:\/\/doi.org\/10.1007\/7651_2022_474","DOI":"10.1007\/7651_2022_474"}],"updated-by":[{"DOI":"10.1007\/s12035-026-05721-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05658-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:34:41Z","timestamp":1770359681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5658"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05658-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the order in which the authors appeared in the author list was incorrectly given as Yumeng Sun, Chao Huang, Yan Pan, Xudong He and Hao Zhang, where it should have been Yumeng Sun, Chao Huang, Yan Pan, Hao Zhang and Xudong He.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-026-05721-2","URL":"https:\/\/doi.org\/10.1007\/s12035-026-05721-2","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"357"}}